Is Lipitor a defective pharmaceutical drug? Our California defective medicine attorneys have a few stories that may help answer this question.
Despite Earning $17 Billion and Paying No Taxes from 2010 through 2012, Pfizer Seeks to Renounce American Citizenship for Tax Benefits
Founded in a red brick building in Brooklyn in 1849, Pfizer, one of America’s oldest companies and the seller of the hugely profitable Viagra and Lipitor, is seeking to renounce its American citizenship and move to climes where it can pay fewer taxes. Despite its huge success in the US with its powerhouse blockbusters bringing [...]
Countless people who took Lipitor (Atorvastatin) and were later diagnosed with type 2 diabetes are seeking to hold Pfizer and its distributors responsible. In California, cases filed throughout the State have been coordinated before Judge Jane Johnson in Los Angeles with an initial status conference held on February 25, 2014. (See JCCP 4761). Judge Johnson [...]
Amid the growing lawsuits and controversy that Pfizer’s Lipitor causes type-2 diabetes in female patients between the ages of 50 and 79 with BMI (Body Mass Index) below 30, (See California coordinated Lipitor cases in Los Angeles Superior Court JCCP no. 4761; In re Lipitor (Atorvastatin) Litigation, MDL No. 2502 (JPML)), Pfizer faces more legal [...]
Thanks to all of our regular readers of The Brandi Law Firm Blog. We try to write about matters that we are involved in representing consumers in the area of defective drugs and devices, consumer issues, and auto safety. We have seen our readership grow by fivefold this year and we thank you for your interest. [...]
Big Pharma: Is Paying Big Fines More Profitable than Telling Doctors and Consumers the Truth in Marketing?
This week, Johnson & Johnson etched its name in the history books of another big pharma company that has been fined over billions of dollars due to a drug manufacturer practices of improper marketing and failure to warn. Johnson & Johnson pled guilty to claims stemming from allegations that the giant pharmaceutical company knowingly marketed [...]
Dr. Eric Topol is a cardiologist with the Scripps Clinic and a recognized pioneer in the field of cardiovascular medicine. For fourteen years, he ran the Cleveland Health Clinic, has authored over 1100 articles and 30 books, and was a founder of the Cleveland Clinic Lerner College of Medicine. An OP Ed article he wrote [...]
Body Mass Index (BMI) Chart for Evaluation of New Onset Diabetes while taking Lipitor, Crestor, or other Statins
In January of 2012, a study published in the medical journal Archives of Internal Medicine found that female patients between the ages of 50 and 79 who took statin medications (i.e., Lipitor and other LDL-lowering drugs) were 48 percent more likely to develop type 2 diabetes as compared to women in the same age group [...]
Faced with a growing number of suits due to the relationship confirmed by medical studies of new onset diabetes in postmenopausal women taking statins including Lipitor, Pfizer confronted two more deteriorating situations at the end of July, declining revenues, and criminal charges leading to a plea. On July 30, 2013, the Justice department announced a [...]
Lipitor is a popular statin medication designed to lower cholesterol levels by inhibiting an enzyme that plays a central role in the production of cholesterol in the liver. We have heard of the "good" cholesterol and the "bad" Cholesterol. Lipitor is prescribed to help prevent the production of low-density lipoproteins (LDLs), also known as the [...]
Medical studies have shown a potential connection between post-menopausal women with a BMI (Body Mass Index) of 30 or below who are taking the prescription medication Lipitor and who are then diagnosed with Type II Diabetes. In a study in the Archive of Internal Medicine (now JAMA Internal Medicine) originally published on January 23, 2012, [...]